Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 249 Breast Neoplasms 197 Glioblastoma 196 Lung Neoplasms 194 Head and Neck Neoplasms 176 Squamous Cell Carcinoma of Head and Neck 166 Prostatic Neoplasms 164 Lymphoma 152 Rectal Neoplasms 131 Central Nervous System Neoplasms 119 Esophageal Neoplasms 117 Leukemia 111 Brain Neoplasms 99 Pancreatic Neoplasms 95 Precursor Cell Lymphoblastic Leukemia-Lymphoma 93 Gliosarcoma 86 Esophageal Squamous Cell Carcinoma 83 Lymphoma, Follicular 81 Sarcoma 80 Lymphoma, Large B-Cell, Diffuse 80 Uterine Cervical Neoplasms 76 Lymphoma, Non-Hodgkin 75 Hodgkin Disease 73 Neoplasms 68 Burkitt Lymphoma 67 Leukemia, Lymphocytic, Chronic, B-Cell 63 Colorectal Neoplasms 63 Glioma 61 Astrocytoma 60 Lymphoma, Large-Cell, Immunoblastic 58

Interventions

Sirolimus 4 LY3295668 erbumine 3 Everolimus 3 Anticonvulsants 2 perampanel 1 clevidipine 1 brivaracetam 1 Vigabatrin 1 Topotecan 1 Therapeutic Touch 1 Temozolomide 1 TAS-119 1 Sulfasalazine 1 Sevoflurane 1 Saline Solution 1 Radiotherapy 1 Propofol 1 Paclitaxel 1 Nitrous Oxide 1 Midazolam 1 Memantine 1 Medical Marijuana 1 Lidocaine 1 Levetiracetam 1 Ketamine 1 Immunoglobulins, Intravenous 1 Glycopyrrolate 1 Gabapentin 1 Fluid Therapy 1 Fentanyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Epilepsy × Radiotherapy × Clear all

NCT05664464 2024-05-10

GLUGLIO

University of Zurich

Phase 1/2 Recruiting

Epilepsy, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡